Download PDF
Thromb Haemost 1999; 81(06): 992-994
DOI: 10.1055/s-0037-1614615
Letters to the Editor
Schattauer GmbH

Evaluation of a New Screening Assay, Protein C Pathway (PCP) Test, for Identification of Defects in the Protein C Pathway

C. Neuwald
1   From the Institute of Laboratory Diagnostics, Kaiser Franz Joseph Spital, Vienna, Austria
,
A. Heinschink
1   From the Institute of Laboratory Diagnostics, Kaiser Franz Joseph Spital, Vienna, Austria
,
M. M. Müller
1   From the Institute of Laboratory Diagnostics, Kaiser Franz Joseph Spital, Vienna, Austria
› Author Affiliations
Further Information

Publication History

Received 12 May 1998

Accepted after resubmission 11 March 1999

Publication Date:
09 December 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Dahlbäck B, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C; predicition of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993; 90: 1004-8.
    CrossrefPubMedGoogle Scholar
  • 2 Griffin JH, Evatt B, Wideman C, Fernandez JA. Anticoagulant Protein C pathway defective in majority of thrombophilic patients. Blood 1993; 82: 1989-93.
    PubMedGoogle Scholar
  • 3 Kraus M, Noah M, Fickenscher K. The PCAT – a simple screening assay for assessing the functionality of the protein C anticoagulant pathway.. Thromb Res 1995; 79: 217-22
    CrossrefPubMedGoogle Scholar
  • 4 Robert E, Eschwege V, Hameg H, Drouet L, Aillaud MF.. Anticoagulant response to Agkistrodon contortrix venom (ACV) test: a new global test to screen for defects in the anticoagulant protein C pathway. Thromb Haemost 1996; 75: 562-5.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Preda L, Simioni P, Legnani C, Palareti G, Pogio M, Rossi E, Girolami A.. A new global test for the evaluation of the protein C-protein S system. Blood Coag Fibrinol 1996; 7 (04) 465-9.
    CrossrefPubMedGoogle Scholar
  • 6 Gable PS, Le DT, McGehee W, Rapaport SI.. A Protac-based screening test for activated protein C-resistant factor Va and other defects of the protein C anticoagulant pathway. Blood Coag Fibrinol 1997; 8 (06) 327-35.
    CrossrefPubMedGoogle Scholar
  • 7 Ruzicka K, Kapiotis S, Quehensberger P, Handler S, Pabinger-Fasching I, Mannhalter C, Jilma B, Speiser W.. Evaluation of new screening assay ProC Global for identification of defects in the protein C/protein S anticoagulant. Thromb Res 1997; 87: 501-10.
    CrossrefPubMedGoogle Scholar
  • 8 Rosen SB, Sturk A. Activated Protein C Resistance – A Major Risk Factor for Thrombosis.. Eur J Clin Chem Biochem 1997; 35 (07) 501-16.
    PubMedGoogle Scholar
  • 9 Tripodi A, Negri B, Bertina RM, Mannucci PM. Screening for the FV:Q506 Mutation – Evaluation of Thirteen Plasma-based Methods for their Diagnostic Efficacy in Comparison with DNA Analysis.. Thromb Haemost 1997; 77 (03) 436-9.
    Article in Thieme ConnectPubMedGoogle Scholar